World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

Aurinia Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company developing in voclosporin, an investigational therapy for the treatment of lupus nephritis and other proteinuric diseases. The headquarters is in Canada.

GH Research PLC is a clinical stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The headquarters is in Ireland.

Bio-pharmaceutical company with headquarters is in Massachusetts, USA.

Taysha Gene Therapies is a Biotechnology company focused on discovering, developing and commercializing gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) both in rare and large patient populations. It is having 10 employees as on 2019. The headquarters is in USA.

Bayer Crop Science is a Biotechnology company providing farmers with the best tools and solutions so they can achieve better harvests using less water, land and energy. The company total assets 29 billion INR. The headquarters is in India.

CanSino Biologics is an Innovative Biopharmaceutical company. It is currently developing 16 vaccine candidates for 13 infectious disease areas, preventing meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. The headquarters is in China.

Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.

Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.

Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.